← All venturesNeurotechnology · NRL-03
Neuralink
Restoring motor and sensory function through neural interface.
12+
Trial participants
4
Trial countries
$9.7B
Latest valuation
650+
Employees
Overview
Neuralink develops implantable brain-computer interfaces designed to restore motor function and communication for people with paralysis, and is developing Blindsight, an experimental device aimed at restoring vision. The company operates through ongoing clinical trials across multiple countries.
Snapshot
- Valuation
- $9.7B
- Change
- +3.6%
- Founded
- 2016
- Headquarters
- Fremont, CA
- Employees
- 650+
Lineup
What Neuralink builds
In progress
Active missions
Interface Clinical Trials
Get involved
Back Neuralink’s next mission.
Other ventures